BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36780067)

  • 1. Familial parathyroid tumours-comparison of clinical profiles between syndromes.
    Figueiredo AA; Saramago A; Cavaco BM; Simões-Pereira J; Leite V
    J Endocrinol Invest; 2023 Sep; 46(9):1799-1806. PubMed ID: 36780067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic defects associated with familial and sporadic hyperparathyroidism.
    Hendy GN; Cole DE
    Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hereditary variants of primary hyperparathyroidism--MEN1, MEN2, HPT-JT, FHH, FIHPT].
    Frank-Raue K; Leidig-Bruckner G; Lorenz A; Rondot S; Haag C; Schulze E; Büchler M; Raue F
    Dtsch Med Wochenschr; 2011 Sep; 136(38):1889-94. PubMed ID: 21915802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism.
    Cetani F; Pardi E; Giovannetti A; Vignali E; Borsari S; Golia F; Cianferotti L; Viacava P; Miccoli P; Gasperi M; Pinchera A; Marcocci C
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):457-64. PubMed ID: 11966738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of parathyroid tumours.
    Thakker RV
    J Intern Med; 2016 Dec; 280(6):574-583. PubMed ID: 27306766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperparathyroidism in hereditary syndromes: special expressions and special managements.
    Marx SJ; Simonds WF; Agarwal SK; Burns AL; Weinstein LS; Cochran C; Skarulis MC; Spiegel AM; Libutti SK; Alexander HR; Chen CC; Chang R; Chandrasekharappa SC; Collins FS
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N37-43. PubMed ID: 12412776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and molecular genetics of parathyroid neoplasms.
    Sharretts JM; Simonds WF
    Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):491-502. PubMed ID: 20833339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathogenesis of primary hyperparathyroidism.
    Cetani F; Pardi E; Borsari S; Marcocci C
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):35-9. PubMed ID: 21985978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.
    Marx SJ; Goltzman D
    J Bone Miner Res; 2019 Jan; 34(1):22-37. PubMed ID: 30536424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13.
    Dwight T; Twigg S; Delbridge L; Wong FK; Farnebo F; Richardson AL; Nelson A; Zedenius J; Philips J; Larsson C; Teh BT; Robinson B
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):85-92. PubMed ID: 10931084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid surgery in familial hyperparathyroid disorders.
    Carling T; Udelsman R
    J Intern Med; 2005 Jan; 257(1):27-37. PubMed ID: 15606374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic studies of a family with hereditary hyperparathyroidism-jaw tumour syndrome.
    Wassif WS; Farnebo F; Teh BT; Moniz CF; Li FY; Harrison JD; Peters TJ; Larsson C; Harris P
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):191-6. PubMed ID: 10396361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine neoplasms in familial syndromes of hyperparathyroidism.
    Li Y; Simonds WF
    Endocr Relat Cancer; 2016 Jun; 23(6):R229-47. PubMed ID: 27207564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial Hyperparathyroidism - Disorders of Growth and Secretion in Hormone-Secretory Tissue.
    Marx SJ; Lourenço DM
    Horm Metab Res; 2017 Nov; 49(11):805-815. PubMed ID: 29136674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
    Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
    Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological correlates of hyperparathyroidism.
    Duan K; Gomez Hernandez K; Mete O
    J Clin Pathol; 2015 Oct; 68(10):771-87. PubMed ID: 26163537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of somatic RET gene mutation in sporadic parathyroid tumors and hyperplasia secondary to uremia, and absence of somatic Men1 gene mutation in MEN2A-associated hyperplasia.
    Uchino S; Noguchi S; Nagatomo M; Sato M; Yamashita H; Yamashita H; Watanabe S; Murakami T; Toda M; Wakiya S; Adachi M
    Biomed Pharmacother; 2000 Jun; 54 Suppl 1():100s-103s. PubMed ID: 10915003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
    Alvelos MI; Vinagre J; Fonseca E; Barbosa E; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
    Eur J Endocrinol; 2013 Feb; 168(2):119-28. PubMed ID: 23093699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1).
    Turner JJ; Christie PT; Pearce SH; Turnpenny PD; Thakker RV
    Hum Mutat; 2010 Jan; 31(1):E1089-101. PubMed ID: 19953642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.
    Cardoso L; Stevenson M; Thakker RV
    Hum Mutat; 2017 Dec; 38(12):1621-1648. PubMed ID: 28881068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.